Amir Emamifar

795 total citations · 1 hit paper
36 papers, 632 citations indexed

About

Amir Emamifar is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Amir Emamifar has authored 36 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Amir Emamifar's work include Vasculitis and related conditions (12 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Systemic Sclerosis and Related Diseases (8 papers). Amir Emamifar is often cited by papers focused on Vasculitis and related conditions (12 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Systemic Sclerosis and Related Diseases (8 papers). Amir Emamifar collaborates with scholars based in Denmark, United States and Russia. Amir Emamifar's co-authors include Inger Marie Jensen Hansen, Søren Hess, Peter Thye‐Rønn, Per Syrak Hansen, Torkell Ellingsen, Oke Gerke, Niels Marcussen, Kristine Bjøerndal, James P. Steinberg and Rosette J. Chakkalakal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and CHEST Journal.

In The Last Decade

Amir Emamifar

35 papers receiving 617 citations

Hit Papers

FRI0203 A SINGLE-CENTER INVESTIGATION ON THE PREVALENCE O... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Emamifar Denmark 11 378 126 106 99 85 36 632
Raquel Ríos-Fernández Spain 17 341 0.9× 73 0.6× 40 0.4× 201 2.0× 191 2.2× 78 950
Toini Uutela Finland 12 234 0.6× 121 1.0× 79 0.7× 49 0.5× 59 0.7× 23 437
Ediz Dalkılıç Türkiye 11 224 0.6× 84 0.7× 40 0.4× 75 0.8× 35 0.4× 72 494
Pilar Macarrón Spain 12 202 0.5× 68 0.5× 39 0.4× 64 0.6× 42 0.5× 20 335
Stefan Kleinert Germany 14 323 0.9× 138 1.1× 43 0.4× 17 0.2× 72 0.8× 52 591
Tarnya Marshall United Kingdom 18 519 1.4× 158 1.3× 90 0.8× 30 0.3× 76 0.9× 38 868
Devis Benfaremo Italy 18 272 0.7× 93 0.7× 35 0.3× 93 0.9× 134 1.6× 53 773
Bóris Afonso Cruz Brazil 15 412 1.1× 255 2.0× 83 0.8× 80 0.8× 45 0.5× 38 668
Marco Fornaro Italy 13 224 0.6× 90 0.7× 28 0.3× 30 0.3× 73 0.9× 56 481

Countries citing papers authored by Amir Emamifar

Since Specialization
Citations

This map shows the geographic impact of Amir Emamifar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Emamifar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Emamifar more than expected).

Fields of papers citing papers by Amir Emamifar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Emamifar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Emamifar. The network helps show where Amir Emamifar may publish in the future.

Co-authorship network of co-authors of Amir Emamifar

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Emamifar. A scholar is included among the top collaborators of Amir Emamifar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Emamifar. Amir Emamifar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emamifar, Amir, Torkell Ellingsen, Anne Pernille Hermann, et al.. (2021). Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis. Scientific Reports. 11(1). 6220–6220. 8 indexed citations
3.
Emamifar, Amir, Søren Hess, Torkell Ellingsen, et al.. (2021). Clinical presentation and treatment response in patients with polymyalgia rheumatica and giant cell arteritis during a 40-week follow-up. Rheumatology Advances in Practice. 5(3). rkab091–rkab091. 2 indexed citations
4.
Emamifar, Amir, Torkell Ellingsen, Søren Hess, et al.. (2020). The Utility of 18F‐FDG PET/CT in Patients With Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross‐sectional Study. ACR Open Rheumatology. 2(8). 478–490. 24 indexed citations
5.
Manzo, Ciro & Amir Emamifar. (2019). Polymyalgia Rheumatica and Seronegative Elderly-Onset Rheumatoid Arthritis: Two Different Diseases with Many Similarities. European Medical Journal. 111–119. 7 indexed citations
6.
Emamifar, Amir, Anne Pernille Hermann, Torkell Ellingsen, et al.. (2019). IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018–Posters Abstracts. Osteoporosis International. 30(S1). 55–114. 2 indexed citations
7.
Emamifar, Amir, Torkell Ellingsen, Anne Pernille Hermann, et al.. (2019). High level of adherence to osteoporosis prophylaxis medications in steroid-treated polymyalgia rheumatica (pmr)/giant cell arteritis (gca) patients: A prospective cohort study. University of Southern Denmark Research Portal (University of Southern Denmark). 30. 1 indexed citations
8.
Emamifar, Amir, Klaus Levin, & Inger Marie Jensen Hansen. (2018). Patients with newly diagnosed rheumatoid arthritis are at increased risk of diabetes mellitus: an observational cohort study.. PubMed. 42(4). 310–317. 10 indexed citations
10.
Emamifar, Amir, Seyed Mohsen Mousavi, & Inger Marie Jensen Hansen. (2017). AB1075 Physician postgraduate experience has a predictive role for physician efficiency index regarding patients with rheumatoid arthritis: a cohort, exploratory study. Annals of the Rheumatic Diseases. 76. 1431–1431.
11.
Kristensen, Lars Erik, Torkell Ellingsen, Robin Christensen, et al.. (2017). Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study. BMJ Open. 7(7). e015536–e015536. 7 indexed citations
12.
15.
Emamifar, Amir & Inger Marie Jensen Hansen. (2017). An update on hearing impairment in patients with rheumatoid arthritis. Journal of Otology. 13(1). 1–4. 12 indexed citations
16.
Emamifar, Amir, Søren Hess, Oke Gerke, et al.. (2017). Polymyalgia rheumatica and giant cell arteritis—three challenges—consequences of the vasculitis process, osteoporosis, and malignancy. Medicine. 96(26). e7297–e7297. 7 indexed citations
18.
Emamifar, Amir, Kristine Bjørndal, & Inger Marie Jensen Hansen. (2016). Rheumatoid arthritis and hearing impairment: a review. Scandinavian Journal of Rheumatology. 45. 2 indexed citations
19.
Emamifar, Amir, et al.. (2016). FDG-PET/CT Findings in a Patient with Polymyalgia Rheumatica and Accompanying Remitting Seronegative Symmetrical Synovitis with Pitting Edema. University of Southern Denmark Research Portal (University of Southern Denmark). 4(4). 1 indexed citations
20.
Ribner, Bruce S., et al.. (2008). Use of a Mandatory Declination Form in a Program for Influenza Vaccination of Healthcare Workers. Infection Control and Hospital Epidemiology. 29(4). 302–308. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026